Name
I10 - Alcohol Use Disorder Treatment in Primary Care
Date & Time
Saturday, October 26, 2024, 10:00 AM - 11:00 AM
Location Name
Presidio B
Description

Less than 10% of patients with Alcohol Use Disorder (AUD) are getting any treatment and less than 4% of patients are prescribed FDA approved medication for AUD. Because treatment for AUD may help to reduce symptoms, morbidity, and mortality, and there is minimal harm in both pharmacotherapy and psychosocial treatments, this presentation will go over these evidence-based treatments that can and may be used in the integrated behavioral healthcare setting. Target audience is for clinicians who have a general understanding of the topic and the language of the topic with an interest in learning more about Alcohol Use Disorder. All disciplines are welcome. 5 minutes: Introduction/negative impact of AUD 10 minutes: Screening and associated Treatment Plan 10 minutes: Acute/intoxicated patient 10 minutes: Psychosocial Management 15 minutes: FDA approved medications for AUD 10 minutes: Q & A

Speakers
Julie Le DO, Physician, UC San Diego Health, San Diego, CA
Julie Le
Content Level
All Audience
Tags
Medical, Patient-centered care or Patient perspectives, Pharmacology, Substance abuse management (e.g., alcohol, tobacco, illicit drugs)
Session Type
Concurrent
SIG or Committee
Medical
Slideshow link
View Slideshow
Objective 1
Summarize assessment tools and diagnostic aides as well as physiological biomarkers to help identify unhealthy alcohol use and AUD
Objective 2
Demonstrate knowledge about evidence-based pharmacological and psychosocial treatments used in various presentations of AUD
Objective 3
Identify 2 FDA approved medications to treat moderate-severe AUD
Content Reference 1

Mintz, Carrie M., et al. “A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and health data to identify gaps in past 12-month care.” Alcoholism: Clinical and Experimental Research 45.6 (2021): 1276-1286

Content Reference 2

Han, Beth, et al. “Use of medications for alcohol use disorder in the US: results from the 2019 National Survey on Drug Use and Health.” JAMA psychiatry 78.8 (2021): 922-924.

Content Reference 3

Reus, Victor I., et al. “The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder.” American Journal of Psychiatry 175.1 (2018): 86-90.

Content Reference 4

Cheng, H. Y., et al. “Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis.” BMJ (Clinical research ed.), (2020): 371, m3934.